Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on AICA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113603721A details a scalable chemical synthesis of SAICAR from Inosine, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing compared to biosynthesis.
Novel five-step synthesis of Baicalein from 2,6-dimethoxy-p-benzoquinone offers high yield and purity for scalable pharmaceutical intermediate manufacturing and supply chain stability.
Novel DAMN-based route offers high yield and purity for anticancer drug precursors, ensuring reliable supply chain and cost efficiency.
Novel 4-step synthesis of 5,6,7-trimethoxybaicalein derivatives via iodine-catalyzed cyclization. High yield, scalable process for anticancer drug development.
Patent CN109879847B reveals a scalable base-catalyzed deuteration method for flavonoids like baicalein and quercetin, offering improved metabolic stability for API development.
Patent CN116768839A reveals a high-purity oroxylin synthesis route. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN1150169C details efficient cyclization of amidine intermediates. High purity API precursors for oncology drugs like Temozolomide.
Patent CN104262311B details a cost-effective one-pot method for baicalein-7-methyl ether. This process enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.